Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q9RP
|
|||
Drug Name |
CBLC137
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Haematological malignancy [ICD-11: 2B33.Y] | Phase 1 | [1] | |
Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | ||
Company |
Incuron Buffalo, NY
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C21H25ClN2O2
|
|||
Canonical SMILES |
CC(C)NCCN1C2=C(C=C(C=C2)C(=O)C)C3=C1C=CC(=C3)C(=O)C.Cl
|
|||
InChI |
1S/C21H24N2O2.ClH/c1-13(2)22-9-10-23-20-7-5-16(14(3)24)11-18(20)19-12-17(15(4)25)6-8-21(19)23;/h5-8,11-13,22H,9-10H2,1-4H3;1H
|
|||
InChIKey |
IXRKBBVMDMKAEB-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1197397-89-9
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.